DE69600065D1 - Dermatologische und/oder pharmazeutische Zubereitung, ihre Herstellung und Anwendung - Google Patents

Dermatologische und/oder pharmazeutische Zubereitung, ihre Herstellung und Anwendung

Info

Publication number
DE69600065D1
DE69600065D1 DE69600065T DE69600065T DE69600065D1 DE 69600065 D1 DE69600065 D1 DE 69600065D1 DE 69600065 T DE69600065 T DE 69600065T DE 69600065 T DE69600065 T DE 69600065T DE 69600065 D1 DE69600065 D1 DE 69600065D1
Authority
DE
Germany
Prior art keywords
dermatological
manufacture
pharmaceutical preparation
pharmaceutical
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69600065T
Other languages
English (en)
Other versions
DE69600065T2 (de
Inventor
Jean-Francois Grollier
Josiane Allec
Isabelle Agostini
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LOreal SA
Original Assignee
LOreal SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9481520&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69600065(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by LOreal SA filed Critical LOreal SA
Publication of DE69600065D1 publication Critical patent/DE69600065D1/de
Application granted granted Critical
Publication of DE69600065T2 publication Critical patent/DE69600065T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/58—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing atoms other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur or phosphorus
    • A61K8/585—Organosilicon compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/89—Polysiloxanes
    • A61K8/891—Polysiloxanes saturated, e.g. dimethicone, phenyl trimethicone, C24-C28 methicone or stearyl dimethicone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q1/00—Make-up preparations; Body powders; Preparations for removing make-up
    • A61Q1/02—Preparations containing skin colorants, e.g. pigments
    • A61Q1/04—Preparations containing skin colorants, e.g. pigments for lips
    • A61Q1/06—Lipsticks

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Birds (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Dermatology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pain & Pain Management (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Virology (AREA)
  • Rheumatology (AREA)
  • Transplantation (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
DE69600065T 1995-07-28 1996-07-05 Dermatologische und/oder pharmazeutische Zubereitung, ihre Herstellung und Anwendung Expired - Fee Related DE69600065T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9509252A FR2737118B1 (fr) 1995-07-28 1995-07-28 Composition dermatologique ou pharmaceutique, procede de preparation et utilisation

Publications (2)

Publication Number Publication Date
DE69600065D1 true DE69600065D1 (de) 1997-10-23
DE69600065T2 DE69600065T2 (de) 1998-01-08

Family

ID=9481520

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69600065T Expired - Fee Related DE69600065T2 (de) 1995-07-28 1996-07-05 Dermatologische und/oder pharmazeutische Zubereitung, ihre Herstellung und Anwendung

Country Status (8)

Country Link
US (1) US6136332A (de)
EP (1) EP0755675B1 (de)
JP (1) JP2965510B2 (de)
AU (1) AU679663B2 (de)
CA (1) CA2182226A1 (de)
DE (1) DE69600065T2 (de)
ES (1) ES2109832T3 (de)
FR (1) FR2737118B1 (de)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2737112B1 (fr) * 1995-07-28 1997-09-05 Oreal Utilisation de l'association de deux huiles particulieres dans une composition notamment cosmetique, et composition obtenue
WO1999040063A1 (fr) * 1998-02-06 1999-08-12 Yoshitomi Pharmaceutical Industries, Ltd. Nouveaux derives de l'acide hydroxamique de type azapeptide
CA2329252A1 (en) * 1998-05-21 1999-11-25 Isis Pharmaceuticals Inc. Compositions and methods for topical delivery of oligonucleotides
FR2787322B1 (fr) * 1998-12-18 2002-10-18 Galderma Res & Dev Emulsion huile-dans-eau comprenant un agent actif micronise et un systeme emulsionnant approprie
GB9828620D0 (en) * 1998-12-23 1999-02-17 Glaxo Group Ltd Medicaments
WO2000061804A1 (en) * 1999-04-14 2000-10-19 Musc Foundation For Research Development Tissue-specific and pathogen-specific toxic agents and ribozymes
US6515029B1 (en) 1999-04-23 2003-02-04 Kimberly-Clark Worldwide, Inc. Absorbent article having a hydrophilic lotionized bodyside liner
DE20017940U1 (de) 2000-10-19 2000-12-28 Map Gmbh Atemmaske zur Zufuhr eines Atemgases zu einem Maskenanwender sowie Ableitungseinrichtung zur Ableitung von Atemgas
US6503526B1 (en) 2000-10-20 2003-01-07 Kimberly-Clark Worldwide, Inc. Absorbent articles enhancing skin barrier function
US6756520B1 (en) 2000-10-20 2004-06-29 Kimberly-Clark Worldwide, Inc. Hydrophilic compositions for use on absorbent articles to enhance skin barrier
US20020128615A1 (en) 2000-12-22 2002-09-12 Tyrrell David John Absorbent articles with non-aqueous compositions containing anionic polymers
US7771735B2 (en) 2000-12-22 2010-08-10 Kimberly-Clark Worldwide, Inc. Absorbent articles with compositions for reducing irritation response
US6749860B2 (en) 2000-12-22 2004-06-15 Kimberly-Clark Worldwide, Inc. Absorbent articles with non-aqueous compositions containing botanicals
MY136633A (en) * 2001-01-17 2008-11-28 Berlin Chemie Ag Stabilized brivudine topical formulations
US7244703B2 (en) 2001-06-22 2007-07-17 Bentley Pharmaceuticals, Inc. Pharmaceutical compositions and methods for peptide treatment
DE10162593A1 (de) * 2001-12-19 2003-07-03 Menarini Ricerche Spa Stabilisierte topische Brivudin-Formulierungen
EP1354586A1 (de) * 2002-04-20 2003-10-22 Aventis Pharma Deutschland GmbH Verwendung von Hydroxypyridon Derivaten zur Wundheilung
JP2005537028A (ja) * 2002-06-26 2005-12-08 ザ　ペン　ステート　リサーチ　ファウンデーション ヒト乳頭腫ウイルス感染症を治療する方法及び材料
US20040151680A1 (en) * 2003-02-05 2004-08-05 Patil Anjali Abhimanyu Cosmetic compositions containing phenyl silicones
US20050025847A1 (en) * 2003-02-26 2005-02-03 Program For Appropriate Technology In Health Microbicidal compositions and method of use
WO2004105662A1 (en) * 2003-05-23 2004-12-09 Program For Appropriate Technology In Health Microbicidal compositions and methods of use
FR2856301B1 (fr) * 2003-06-23 2007-08-03 Galderma Res & Dev Composition sous forme de spray comprenant un actif pharmaceutique, au moins un silicone volatile et une phase non polaire non volatile
BRPI0418589A (pt) 2003-12-08 2008-01-29 Bentley Pharmaceuticals Inc composições farmacêuticas e métodos para tratamento por insulina
US20060014834A1 (en) * 2004-05-11 2006-01-19 Mohan Vishnupad Retinoid solutions and formulations made therefrom
US7662855B2 (en) * 2004-05-11 2010-02-16 Imaginative Research Associates, Inc. Retinoid solutions and formulations made therefrom
CA2567636A1 (en) * 2004-06-17 2005-12-29 Galderma S.A. Composition for the treatment of psoriasis comprising a silicone agent, a corticosteroid and vitamin d or a derivative thereof
FR2871695B1 (fr) * 2004-06-17 2008-07-04 Galderma Sa Composition pharmaceutique comprenant un agent silicone et deux principes actifs solubilises
FR2871698B1 (fr) * 2004-06-17 2008-07-04 Galderma Sa Composition sous forme de spray comprenant une association d'actifs pharmaceutiques et une phase huileuse
BRPI0511389A (pt) * 2004-06-17 2007-12-04 Galderma Sa composição e seu uso
DK1771180T4 (da) * 2004-06-17 2011-04-11 Galderma Sa Sammensætning i form af en spray, der omfatter en kombination af clobetasolpropionat og calcitriol, en alkoholfase og en oliefase
FR2871700B1 (fr) * 2004-06-17 2006-11-17 Galderma Sa Composition sous forme de spray comprenant une association d'actifs pharmaceutiques, une phase alcoolique, et une phase huileuse
FR2871697B1 (fr) * 2004-06-17 2007-06-29 Galderma Sa Composition sous forme de spray comprenant une association d'actifs pharmaceutiques, une phase alcoolique, au moins un silicone volatile et une phase huileuse non volatile
JP5535425B2 (ja) * 2006-12-22 2014-07-02 メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツング フィラー、その製造方法、および化粧料
US20080188446A1 (en) * 2007-02-02 2008-08-07 Warner Chilcott Company Inc. Tetracycline compositions for topical administration
WO2008097850A1 (en) * 2007-02-02 2008-08-14 Warner Chilcott Company, Inc. Tretracycline compositions for topical administration
US20110092493A1 (en) * 2008-09-24 2011-04-21 Clark Levi Dose-controlled transdermal promethazine compositions and methods of use
CA2738496C (en) * 2008-09-30 2020-07-28 The Hospital For Sick Children Compositions for proliferation of cells and related methods
US8748177B2 (en) 2008-09-30 2014-06-10 The Hospital For Sick Children Compositions for proliferation of cells and related methods
GB0919650D0 (en) * 2009-11-10 2009-12-23 Futura Medical Developments Ltd Pharmaceutical composition
US20140357729A1 (en) * 2011-12-21 2014-12-04 Maruho Co., Ltd. Topical composition containing silicone base
WO2013190703A1 (en) 2012-06-21 2013-12-27 L'oreal Cosmetic solid composition comprise a non volatile hydrocarbonated oil, waxes and a high content from non volatile phenylated silicone oil
JP2014141475A (ja) * 2012-12-27 2014-08-07 Daiichi Sankyo Co Ltd 新規美白剤
US8883747B1 (en) * 2013-10-09 2014-11-11 Craig W. Carver Topical antifungal compositions and methods of use thereof
US20190083379A1 (en) 2017-09-18 2019-03-21 Mast Industries (Far East) Limited Gloss lip balm formulation
US20210038616A1 (en) * 2018-03-30 2021-02-11 Rohto Pharmaceutical Co., Ltd. Solid oily external composition

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU560740B2 (en) * 1984-01-09 1987-04-16 Unilever Plc Pharmaceutical emulsion comprising an organic lactate and silicone oil
CA1272136A (en) * 1985-04-02 1990-07-31 Grish Chandra Substantive skin care compositions comprising a polydiorganosiloxane
US4992478A (en) * 1988-04-04 1991-02-12 Warner-Lambert Company Antiinflammatory skin moisturizing composition and method of preparing same
JPH02258718A (ja) * 1989-03-31 1990-10-19 Nippon Kayaku Co Ltd ペースト状基剤及び製剤
US5444096A (en) * 1989-06-02 1995-08-22 Helene Curtis, Inc. Stable anhydrous topically-active composition and suspending agent therefor
JPH05201851A (ja) * 1992-01-30 1993-08-10 Toshiba Silicone Co Ltd 化粧用洗浄剤
JP3197640B2 (ja) * 1992-11-30 2001-08-13 朝日興業株式会社 気泡発生装置
CA2107253C (en) * 1992-12-15 1998-04-21 Anthony Castrogiovanni Cosmetic compositions with improved transfer resistance
FR2701845B1 (fr) * 1993-02-23 1995-04-07 Oreal Emulsion eau-dans-huile à usage cosmétique ou pharmaceutique.
FR2702653B1 (fr) * 1993-03-16 1995-05-24 Oreal Utilisation en cosmétique ou en application topique d'une dispersion aqueuse à base d'organopolysiloxanes non volatils et d'un polymère réticulé de chlorure de méthacryloyloxyéthyl triméthylammonium .
FR2710843B1 (fr) * 1993-10-04 1995-12-01 Oreal Composition d'organopolysiloxane d'aspect gélifié, sans gélifiant, utilisable en cosmétique et dermatologie.
FR2715294B1 (fr) * 1994-01-26 1996-03-22 Oreal Composition cosmétique ou dermatologique anhydre contenant l'association d'une huile de silicone et d'une cire d'un homo- ou copolymère d'éthylène .
US5531986A (en) * 1994-07-01 1996-07-02 The Mennen Company Low residue antiperspirant solid stick composition

Also Published As

Publication number Publication date
AU679663B2 (en) 1997-07-03
EP0755675A1 (de) 1997-01-29
FR2737118A1 (fr) 1997-01-31
AU5943096A (en) 1997-02-13
FR2737118B1 (fr) 1997-09-05
CA2182226A1 (fr) 1997-01-29
DE69600065T2 (de) 1998-01-08
JP2965510B2 (ja) 1999-10-18
US6136332A (en) 2000-10-24
JPH0940548A (ja) 1997-02-10
ES2109832T3 (es) 1998-01-16
EP0755675B1 (de) 1997-09-17

Similar Documents

Publication Publication Date Title
DE69600065D1 (de) Dermatologische und/oder pharmazeutische Zubereitung, ihre Herstellung und Anwendung
CY2007001I1 (el) Φαρμακευτικο σκευασμα για χρηση στη θεραπεια του διαβητη
DE69928260D1 (de) Schwefel-substituierte sulfonylaminocarbonsäure n-arylamide, ihre herstellung, ihre anwendung und diese enthaltende pharmazeutische zusammensetzungen
DE69606028T2 (de) Taxal derivate, deren herstellung und diese enthaltende pharmazeutische zusammensetzung
DE69618587T2 (de) Chinazoline und pharmazeutische zusammensetzungen
ATE288419T1 (de) Alpha-aryl-n-alkylnitrone sowie diese enthaltende pharmazeutische zubereitungen
EE9600172A (et) Puriin-6-ooni derivaadid, nende valmistamismeetod, kasutamine ravimite valmistamiseks ja ravimid
EE04151B1 (et) Atsüülpiperasinüülpürimidiinide derivaadid, nendevalmistamine ja kasutamine ravimitena
DE59704397D1 (de) Kosmetische und/oder pharmazeutische zubereitungen
DE59905572D1 (de) Substituierte 4-amino-2-aryl-pyrimidine, ihre herstellung, ihre verwendung und sie enthaltende pharmazeutische präparate
ATE243708T1 (de) Substituierte imidazolidinderivate, ihre herstellung, ihre verwendung und sie enthaltende pharmazeutische präparate
DE59607535D1 (de) Kosmetische und/oder pharmazeutische zubereitungen
DE68907559T2 (de) Sulfoniumsalze, ihre Anwendung und ihre Herstellung.
DE69704060D1 (de) Tetrahydroisochinolinderivate und ihre pharmazeutische anwendung
ATE449786T1 (de) Imidazolidinderivate, ihre herstellung, ihre verwendung und sie enthaltende pharmazeutische präparate
FI956298A0 (fi) 3-fenyyli-isokinolin-1(2H)-oneja, niiden valmistus ja terapeuttinen käyttö
DE69808921D1 (de) 4-OXO-3,5-DIHYDRO-4H-PYRIDAZINO[4,5-b]INDOL-1-ACETAMID-DERIVATE, IHRE HERSTELLUNG UND THERAPEUTISCHE ANWENDUNG
ATE252096T1 (de) Prolylendopeptidase-inhibitoren, ihre herstellung und ihre pharmazeutische verwendung
DE3776620D1 (de) 3-propenylcephemderivate, ihre herstellung, zwischenverbindungen, pharmazeutische praeparate und anwendung.
DE69706146D1 (de) Taxoide, ihre herstellung und diese enthaltende pharmazeutische zusammensetzungen
DE59505714D1 (de) Kosmetische und/oder pharmazeutische zubereitungen
DE69905714T2 (de) Platinkomplex, dessen herstellung und dessen therapeutische anwendung
DE50006823D1 (de) Kosmetische und/oder pharmazeutische zubereitungen
ATE198192T1 (de) Benzolsulfonamidderivate, ihre herstellung und ihre therapeutische verwendung
EE200000207A (et) 8-asabitsüklo[3.2.1]oktaan-3-metaanamiini derivaadid, nende valmistamine ja terapeutiline kasutamine

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee